SCHEMBL6728051

SCHEMBL6728051

Clc1ccc(CC(NC2=NCCC2)c2cccc(Cl)c2Cl)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
KMT2A Q03164 2/20 0.37
PNMT P11086 1/20 0.37
POLB P06746 2/20 0.35
TAAR1 Q96RJ0 1/20 0.35
CYP2D6 P10635 2/20 0.34
MEN1 O00255 1/20 0.34
WDR5 P61964 3/20 0.33
NPC1 O15118 1/20 0.33
F2 P00734 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SIGMAR1 Q99720 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALOX15 P16050 1/20 0.32
NISCH Q9Y2I1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6728673 0.87 KMT2A (0.40) ALDH1A1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL6728514 0.87 ADRA2A (0.45) ALDH1A1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL6727985 0.86 ALDH1A1 (0.43) ALDH1A1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL6727571 0.85 ALDH1A1 (0.41) ALDH1A1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL6728116 0.84 TAAR1 (0.40) ALDH1A1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL6727683 0.83 KMT2A (0.41) ALDH1A1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL3236268 0.82 HSD17B10 (0.51) ALDH1A1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL6727948 0.81 KMT2A (0.41) ALDH1A1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL4111441 0.80 WDR5 (0.45) ADRA2AADRA2BADRA2CKMT2ACYP2D6
SCHEMBL6727927 0.79 ADRA2A (0.47) ALDH1A1ADRA2AADRA2BADRA2CKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370430-B1 N-(1-PHENYL-2-ARYLETHYL)-4,5-DIHYDRO-3H-PYRROL-2-AMINE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA2B OR ALPHA2B AND ALPHA2C ADRENOCEPTORS ALLERGAN INC (US) 2014-06-04 EP disclosed
US-8183414-B2 N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptors ALLERGAN, INC. (US) 2012-05-22 US disclosed
US-8183414-B2 N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptors ALLERGAN, INC. (US) 2012-05-22 US disclosed
US-20100145061-A1 N-(1-PHENYL-2-ARYLETHYL)-4,5-DIHYDRO-2H-PYRROL-5-AMINE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA2B OR ALPHA2B AND ALPHA2C ADRENOCEPTORS ALLERGAN, INC. (US) 2010-06-10 US disclosed
US-20100145061-A1 N-(1-PHENYL-2-ARYLETHYL)-4,5-DIHYDRO-2H-PYRROL-5-AMINE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA2B OR ALPHA2B AND ALPHA2C ADRENOCEPTORS ALLERGAN, INC. (US) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145061-A1 N-(1-PHENYL-2-ARYLETHYL)-4,5-DIHYDRO-2H-PYRROL-5-AMINE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA2B OR ALPHA2B AND ALPHA2C ADRENOCEPTORS ADRA2B, ADRB2, ADRA2C ALDH1A1 559/4885ADRA2A 6/4885ADRA2B 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.